The significance of anthropometric and endocrine parameters in ovulation induction with clomiphene citrate in women with polycystic ovary syndrome

References

1. ↵
   1. Franks S,
   2. Stark J,
   3. Hardy K

   (2008) Follicle Dynamics and anovulation in polycystic ovary syndrome. Hum Reprod Update 14:367–378.

   OpenUrlCrossRefPubMedWeb of Science
2. ↵
   1. Stein IF,
   2. Leventhal ML

   (1935) Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 29:181–191.

   OpenUrlCrossRefWeb of Science
3. ↵
   1. Yildiz BO,
   2. Bozdag G,
   3. Yapici Z,
   4. Esinler I,
   5. Yarali H

   (2012) Prevalence, phenotype and cardio-metabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod 27:3067–3073.

   OpenUrlCrossRefPubMedWeb of Science
4. ↵
   1. Dickey RP,
   2. Holtkamp DE

   (1996) Development, pharmacology and clinical experience with clomiphene citrate. Hum Reprod Update 2:483–506.

   OpenUrlCrossRefPubMedWeb of Science
5. ↵
   1. Imani B,
   2. Eijkemans MJ,
   3. Velde ER,
   4. Habbema JD,
   5. Fauser BC

   (1998) Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 83:2361–2365.

   OpenUrlCrossRefPubMedWeb of Science
6. ↵
   1. Gysler M,
   2. March CM,
   3. Mishell DR Jr.,
   4. Bailey EJ

   (1982) A decade’s experience with an individualized clomiphene treatment regimen including its effect on the postcoital test. Fertil Steril 37:161–167.

   OpenUrlPubMedWeb of Science
7. ↵
   1. Filicori M

   (1999) The role of luteinizing hormone in folliculogenesis and ovulation induction. Fertil Steril 71:405–414.

   OpenUrlCrossRefPubMedWeb of Science
8. ↵
   1. Ho JY,
   2. Guu HF,
   3. Yi YC,
   4. Chen MJ,
   5. Ho ES

   (2005) The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict “low responders.” Fertil Steril 83:883–888.

   OpenUrlCrossRefPubMedWeb of Science
9. ↵
   1. Shoham Z,
   2. Jacobs HS,
   3. Insler V

   (1993) Luteinizing hormone: its role, mechanism of action, and detrimental effects when hypersecreted during the follicular phase. Fertil Steril 59:1153–1161.

   OpenUrlPubMedWeb of Science
10. ↵
    1. Hillier SG,
    2. Whitelaw PF,
    3. Smyth CD

    (1994) Follicular estrogen synthesis: the ‘two-cell, two-gonadotropin’ model revisited. Mole Cell Endocrinol 100:51–54.

    OpenUrl
11. ↵
    1. Farhi J,
    2. Soule S,
    3. Jacobs HS

    (1995) Effect of laparoscopic ovarian electrocautery on ovarian response and outcome of treatment with gonadotropins in clomiphene citrate-resistant patients with polycystic ovary syndrome. Fertil Steril 64:930–935.

    OpenUrlPubMedWeb of Science
12. ↵
    1. Willis DS,
    2. Watson H,
    3. Mason HD,
    4. Galea R,
    5. Brincat M,
    6. Franks S

    (1998) Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation. J Clin Endocrinol Metab 83:3984–3991.

    OpenUrlCrossRefPubMedWeb of Science
13. ↵
    1. Franks S,
    2. Stark J,
    3. Hardy K

    (2008) Follicle Dynamics and anovulation in polycystic ovary syndrome. Hum Reprod Update 14:367–378.

    OpenUrlCrossRefPubMedWeb of Science
14. ↵
    1. Barber TM,
    2. Wass JA,
    3. McCarthy MI,
    4. Franks S

    (2007) Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome. Clin Endocrinol 66:513–517.

    OpenUrlPubMed
15. 1. Conway GS,
    2. Honour JW,
    3. Jacobs HS

    (1989) Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clin Endocrinol (Oxford) 30:459–470.

    OpenUrlCrossRefPubMed
16. 1. Dunaif A,
    2. Graf M,
    3. Mandeli J,
    4. Laumas V,
    5. Dobrjansky A

    (1987) Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab 65:499–507.

    OpenUrlCrossRefPubMedWeb of Science
17. ↵
    1. Robinson S,
    2. Kiddy D,
    3. Gelding SV,
    4. Willis D,
    5. Niththyananthan R,
    6. Bush A,
    7. et al.

    (1993) The relationship of insulin in sensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clin Endocrinol 39:351–355.

    OpenUrlCrossRefPubMed
18. ↵
    1. Akpinar F,
    2. Demir B,
    3. Dilbaz S,
    4. Kaplanoğlu I,
    5. Dilbaz B

    (2014) Obesity is not associated with the poor pregnancy outcome following intracytoplasmic sperm injection in women with polycystic ovary syndrome. J Turk Ger Gynecol Assoc 15:144–148.

    OpenUrl
19. ↵
    1. Nestler JE,
    2. Powers LP,
    3. Matt DW,
    4. Steingold KA,
    5. Plymate SR,
    6. Rittmaster RS,
    7. et al.

    (1991) A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab 72:83–89.

    OpenUrlCrossRefPubMedWeb of Science